Zoetis, Inc. (ZTS)
77.17
-0.56
(-0.72%)
USD |
NYSE |
Aug 24, 16:00
77.15
-0.02
(-0.03%)
Pre-Market: 04:05
Zoetis Net Income (Quarterly) : 691.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 691.00M |
| March 31, 2026 | 601.00M |
| December 31, 2025 | 603.00M |
| September 30, 2025 | 721.00M |
| June 30, 2025 | 726.00M |
| March 31, 2025 | 602.00M |
| December 31, 2024 | 581.00M |
| September 30, 2024 | 692.00M |
| June 30, 2024 | 624.00M |
| March 31, 2024 | 599.00M |
| December 31, 2023 | 523.00M |
| September 30, 2023 | 596.00M |
| June 30, 2023 | 670.00M |
| March 31, 2023 | 551.00M |
| December 31, 2022 | 460.00M |
| September 30, 2022 | 528.00M |
| June 30, 2022 | 529.00M |
| March 31, 2022 | 594.00M |
| December 31, 2021 | 413.00M |
| September 30, 2021 | 552.00M |
| June 30, 2021 | 511.00M |
| March 31, 2021 | 558.00M |
| December 31, 2020 | 358.00M |
| September 30, 2020 | 479.00M |
| June 30, 2020 | 376.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 423.00M |
| December 31, 2019 | 384.00M |
| September 30, 2019 | 433.00M |
| June 30, 2019 | 371.00M |
| March 31, 2019 | 312.00M |
| December 31, 2018 | 345.00M |
| September 30, 2018 | 347.00M |
| June 30, 2018 | 382.00M |
| March 31, 2018 | 350.00M |
| December 31, 2017 | 80.00M |
| September 30, 2017 | 296.00M |
| June 30, 2017 | 247.00M |
| March 31, 2017 | 239.00M |
| December 31, 2016 | 154.00M |
| September 30, 2016 | 237.00M |
| June 30, 2016 | 224.00M |
| March 31, 2016 | 204.00M |
| December 31, 2015 | 20.00M |
| September 30, 2015 | 190.00M |
| June 30, 2015 | -36.00M |
| March 31, 2015 | 165.00M |
| December 31, 2014 | 126.00M |
| September 30, 2014 | 167.00M |
| June 30, 2014 | 139.00M |
| March 31, 2014 | 155.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.337B |
| Elanco Animal Health, Inc. | 54.00M |
| Boston Scientific Corp. | 905.00M |
| Pfizer Inc. | -246.00M |
| Phibro Animal Health Corp. | 24.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.468B |
| Total Expenses (Quarterly) | 1.777B |
| EPS Diluted (Quarterly) | 1.654 |
| Enterprise Value | 39.52B |
| Gross Profit Margin (Quarterly) | 71.47% |
| Profit Margin (Quarterly) | 28.00% |
| Earnings Yield | 7.88% |
| Operating Earnings Yield | 10.79% |
| Normalized Earnings Yield | 8.142 |